Skip to content

Opening book details…

Can I read Hemanext Inc. Announces First Patients Treated in A Clinical Trial Investigating The Efficacy of The Hemanext ONE® Red Blood Cell Processing and Storage System on EtoBox?

Hemanext Inc. Announces First Patients Treated in A Clinical Trial Investigating The Efficacy of The Hemanext ONE® Red Blood Cell Processing and Storage System by PR.com is a document available to read on EtoBox.

What is Hemanext Inc. Announces First Patients Treated in A Clinical Trial Investigating The Efficacy of The Hemanext ONE® Red Blood Cell Processing and Storage System about?

Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, announces that the first two patients enrolled have begun receiving transfusions in a multi-center, randomized, controlled cross-over study to evaluate the safety and effectiveness of hypoxic red blood cells processed with the Hemanext ONE® System versus conventional red blood cells in patients with transfusion-dependent

Author
PR.com
Language
EN